Strong Collaboration, Innovation Leads the Future | Siraimei Biotechnology and Xiaofu Technology Explore the New Blue Ocean of Skin Health Together
With the widespread application of biomaterials in medical and skincare fields, consumers' demand for safe, efficient, and naturally rich skincare products continues to grow. Recently, Siraimei Biotechnology (Zhejiang) Co., Ltd. (hereinafter referred to as "Siraimei Biotechnology") and Hangzhou Xiaofu Technology Co., Ltd. (hereinafter referred to as "Xiaofu Technology") officially signed a strategic cooperation agreement. Zhao Hongshi, the head of Siraimei Biotechnology, and Xiao Ning, the head of Xiaofu Technology, attended and signed the agreement on behalf of both parties.
Both parties will carry out in-depth cooperation in the field of skin health, integrate their advantageous resources, adhere to the principle of mutual benefit and trust, innovate skincare technology, and promote the development of skin health towards high efficiency, precision, and personalization.
Zhao Hongshi, the head of Siraimei Biotechnology, stated that Siraimei Biotechnology focuses on the research and application of instant and high-purity medical silk fibroin materials, and has taken the lead in realizing the industrialization of small molecule silk fibroin, forming an integrated development pattern of research and development, production, and sales of medical devices, medical beauty, and skincare products. The development concepts of both parties are highly compatible, and they hope to accelerate the transformation and application of scientific research achievements through various forms such as project cooperation and joint research and development. In the subsequent cooperation, Siraimei Biotechnology will continue to fully utilize its brand and product advantages, lay out the marketization process of silk fibroin raw materials and products, intensify the new track of the future skincare industry, accelerate business integration with Xiaofu Technology, and transform the strategic cooperation agreement into mutually beneficial and win-win results.
Xiao Ning, the head of Xiaofu Technology, stated that Xiaofu Technology is committed to building a digital ecosystem for medical beauty based on digital imaging diagnosis technology. By using AI algorithms to accurately obtain skin feature data, it provides consumers with high-quality and comprehensive skin health solutions. At the same time, the company actively links various partners, integrates multiple resources, and positions customer needs. In this cooperation, Xiaofu Technology will fully leverage its digital advantages to provide strong data support for Siraimei Biotechnology. Both parties will strengthen their interaction mechanism, achieve efficient resource sharing and seamless information integration, and jointly create an innovative ecosystem in the field of skin health.
The successful signing of this strategic cooperation agreement is due to the similar skincare concepts and complementary advantageous resources of Siremei Biotechnology and Xiaofu Technology. Both parties will take this as an opportunity to build an ideal cooperation model that intersects horizontally and vertically, jointly grasp the new trends in market development, and explore new formats in the skincare industry. In the future, both sides will work together to develop the industry towards digitization, intelligence, and health, and jointly lead the new trend of innovative development in the industry.
